 |
Arvelle Therapeutics
Last updated: March 04, 2024
Mark Altmeyer - Founder, CEO
Country: Switzerland | Funding: $221.8M (+)
Website: http://arvelletx.com/
Arvelle carries forward the European rights to cenobamate, an anti-epileptic drug for partial-onset seizures
Website: http://arvelletx.com/
Arvelle carries forward the European rights to cenobamate, an anti-epileptic drug for partial-onset seizures